drugset / Trial / NCT04026945
Sustained Release Lidocaine for Treatment of Scrotal Pain
NaSingle-groupOpen-labelTreatment
Summary
In this study, the investigators are testing a new formulation of lidocaine for its suitability in managing chronic scrotal pain (CSCP). The new formulation ST-CP is a lidocaine sustained-release formulation and is expected to provide pain relief over 4 weeks. Currently, the drug lidocaine is not available as an injectable slow-release formulation and chronic scrotal pain patients are often left untreated.
Timeline
- Start
- 2019-10-31
- Primary completion
- 2021-03-24
- Completion
- 2021-03-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 280 mg | Other |
| Subject | Lidocaine | Other / unclassified | 420 mg | Other |
| Subject | Lidocaine | Other / unclassified | 560 mg | Other |